Latest in Moderna’s Experimental Mpox
Sort by
3 items
-
Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion
Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year.CNBC - 1d -
Moderna’s stock tumbles to post-COVID lows after revenue outlook disappoints
Moderna’s stock tumbles after a disappointing outlook for revenue and the need to accelerate its cost-cutting plan.MarketWatch - 1d -
